Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 09 - 20 symbols : GILD save search
Veru Announces Positive Updated Data from Phase 1b/2 Sabizabulin Study in Men with Metastatic Castration Resistant Prostate Cancer at the 2021 ESMO Congress
Published: 2021-09-20 (Crawled : 13:15) - biospace.com/
VERU | $1.305 -8.1% -8.81% 2.6M
|
Health Technology
|
| O: -4.25%
H: 3.62%
C: -1.17%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.14%
H: 1.4%
C: 0.04%
prostate cancer phase 1 positive cancer phase 1b sabizabulin phase 2b
Aadi Bioscience Appoints Brendan Delaney as Chief Operating Officer
Published: 2021-09-20 (Crawled : 13:00) - biospace.com/
AADI | $1.835 1.94% 1.91% 140K
|
Manufacturing
|
| O: -0.07%
H: 0.07%
C: -0.82%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 0.16%
H: 3.69%
C: 2.54%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.14%
H: 1.4%
C: 0.04%
bioscience
Gilead to Present Latest Antiviral Research Data Addressing Urgent Global Needs in Infectious Disease at IDWeek 2021
Published: 2021-09-20 (Crawled : 13:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.14%
H: 1.4%
C: 0.04%
disease infectious disease test antiviral research
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.